Innovating Works

CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP

Inactiva
Mostrando 1 al 20 de 109 resultados
REACTIVA: The transcriptional regulation of cardiomyocyte polyploidization and its relevance in cardiac regene... CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un HORIZON EUROPE: ERC-2023-ADG The mammalian heart is a non-regenerative organ due to the extremely limited ability of fully differentiated cardiomyocytes (CMs) to prolife...
2024-05-14 - 2029-09-30 | Financiado
ImnovAth: Targeting the Imidazoline I1 receptor as a novel treatment for Atherosclerosis CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un HORIZON EUROPE: ERC-2023-POC Atherosclerosis (AT) is one of the main causes of death worldwide. Current treatments (e.g. lipid-lowering therapies) are still insufficient...
2024-03-08 - 2026-02-28 | Financiado
ABCardionostics: Human Antibody-enabled Cardiovascular Personalized Theranosis UNIVERSITE DE BORDEAUX tramitó un HORIZON EUROPE: HORIZON-EIC-2023-PATHFINDEROPEN-01 ABCardionostics envisions an innovative multi-marker-based positron emission tomography (PET)/ magnetic resonance imaging (MRI) system for e...
2024-02-29 - 2028-03-31 | Financiado
CURE HEARTandBRAIN: CURE HEARTandBRAIN postdoctoral COFUND programme by CNIC CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-COFUND-01 The CNIC (Spanish Centre for Cardiovascular Research) is a worldwide recognised research centre dedicated to cardiovascular research. CNIC’s...
2023-09-19 - 2028-12-31 | Financiado
DCM-NEXT: Enabling advances in diagnosis, patient stratification and treatment for dilated cardiomyopathy pati... STICHTING AMSTERDAM UMC tramitó un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDERCHALLENGES-01 Dilated Cardiomyopathy (DCM) is a heart muscle disorder characterised by thinning and stretching of the heart ventricles, making it harder f...
2023-06-20 - 2027-09-30 | Financiado
DILEMMA: DecIphering nucLEar Mechanics in diabetes: a Multi-scAle perspective CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-PF-01 DILEMMA will orient fundamental research to fill a gap in diabetes mellitus (DM) biology, by addressing a relevant biomedical problem in a c...
2022-04-28 - 2024-05-31 | Financiado
ProtMechanics-Live: Uncovering Protein Mechanics in Physiology and Disease CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un H2020: ERC-2020-COG Protein mechanics is a key contributor to the form and function of biological systems by mechanisms that are just starting to be unraveled....
2021-02-16 - 2026-05-31 | Financiado
AngioUnrestUHD: Understanding and modulating vascular arrest with ultra high definition CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un H2020: ERC-2020-COG Therapeutic modulation of vascular cell proliferation and migration is essential for the effective inhibition of angiogenesis in cancer or i...
2021-02-16 - 2026-02-28 | Financiado
RESILIENCE: Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines. CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un H2020: H2020-SC1-BHC-2018-2020 The increasing life expectancy of the population and the development of effective therapies result in a growing population of aged cancer su...
2021-01-29 - 2026-05-31 | Financiado
MAESTRIA: Machine Learning Artificial Intelligence Early Detection Stroke Atrial Fibrillation SORBONNE UNIVERSITE tramitó un H2020: H2020-SC1-BHC-2018-2020 Atrial fibrillation (AF) and stroke are major health care problems in Europe. They are most often the clinical expression of atrial cardiomy...
2021-01-21 - 2026-02-28 | Financiado
RITA-MI 2: Rituximab in patients with acute myocardial infarction a phase 2 placebo controlled randomised clin... INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un H2020: H2020-SC1-BHC-2018-2020 RITA-MI 2 will assess the impact of a novel therapeutic strategy targeting patients’ immune response on the recovery of heart function after...
2021-01-18 - 2026-05-31 | Financiado
STIMULATE: STING signalling modulation via the Electron Transport Chain CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un H2020: H2020-MSCA-IF-2019 The innate immune response to cytosolic dsDNA via the cGAS-STING pathway has been shown to be essential in the response to various viral, ba...
2020-03-04 - 2023-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.